New VigiLyze developments set to improve analysis and sharing The previous update of VigiLyze went live in May but there’s been no let-up in the pace of development.
COVID-19 top priority for research team Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Boosting signal detection efficiency in Norway Implementing VigiLyze as the main signal detection tool in the Norwegian Medicines Agency resulted in a more streamlined and efficient signal management process.
National centres share experience at 42nd annual meeting The 42nd Annual NC meeting drew the global pharmacovigilance community to Bogotá, Colombia for an intensive programme of learning, experience sharing and inspiration.
Unmasking data in the COVID-19 vaccine era First came the COVID-19 pandemic. Then came the COVID-19 vaccines. Then came millions of COVID-19 vaccine reports of suspected side effects. What are the implications of that?
